U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the COVID pandemic and has shown promise in addressing a ran ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

Supporters say consumers should be protected from unknowingly eating material from novel vaccines, which are similar to COVID ...

Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $70.0 for Moderna over the recent three months. In terms of liquidity ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...